Figure 2: Visible improvement in repigmentation of neck and trunk in patients who applied
ruxolitinib cream 1.5% twice daily. Representative clinical images of patients from the TRuE-V1/2
study. T-VASI scores include the face. T-VASI, Total Vitiligo Scoring Index.